Breaking News Instant updates and real-time market news.

AMRN

Amarin

$2.86

-0.1 (-3.38%)

07:26
07/19/18
07/19
07:26
07/19/18
07:26

Amarin's Vascepa remains underappreciated, says Cantor Fitzgerald

Cantor Fitzgerald analyst Louise Chen points out that Amarin's Reduce-It trial was highlighted in a Journal of the American review article titled "Unmet Need for Adjunctive Dyslipidemia Therapy in Hypertriglyceridemia Management." The analyst believes this supports her view that the market opportunity for Vascepa is still underappreciated. The paper highlights the unmet need for addressing residual risk for major adverse cardiovascular events even after intensive statin therapy, Chen tells investors in a research note. The analyst keeps an Overweight rating on Amarin shares with a $10 price target.

AMRN Amarin
$2.86

-0.1 (-3.38%)

02/20/18
CANT
02/20/18
NO CHANGE
Target $10
CANT
Overweight
Amarin shares compelling ahead of data, Cantor Fitzgerald
Amarin shares represent a "compelling investment opportunity" ahead of data for the company's Reduce-It study before the end of Q3, Cantor Fitzgerald analyst Louise Chen wrote Friday in a research note to investors. She expects the data to be positive. Amarin recently raised $70M and could raise up to another $10.5M gross, if overallotment is exercised, ahead of the data readout which removes a financing overhang and accelerates the company's plan to expand its sales and promotion of Vascepa, Chen argues. She keeps an Overweight rating on the shares with a $10 price target.
03/01/18
HCWC
03/01/18
NO CHANGE
Target $10
HCWC
Buy
Amarin has 'significant upside' on positive trial data, says H.C. Wainwright
H.C. Wainwright analyst Andrew Fein continues to believe that Amarin's current valuation is supported by Vascepa sales alone. The potential success of the Reduce-It trial represents "significant upside," Fein tells investors in a research note. He reiterates a Buy rating on Amarin with a $10 price target following the company's Q4 results.
04/09/18
JEFF
04/09/18
NO CHANGE
Target $7
JEFF
Buy
Amarin risk/reward favorable into Q3 data, says Jefferies
Jefferies analyst Matthew Andrews surveyed 50 U.S. physicians and high prescribers of Amarin's Vascepa to assess current use of Vascepa in mixed dyslipidemia and severe high triglycerides, and future prescribing habits based on the REDUCE-IT data. The survey indicates Vascepa is the leading triglycerides-lowering drug in severe hypertriglyceridemia and mixed dyslipidemia, and positive MACE data in the REDUCE-IT trial could increase use 125% and 50%, respectively, Andrews tells investors in a research note. The analyst estimates peak-adjusted U.S. Vascepa sales of $1.06B by 2030. He sees a favorable risk/reward on Amarin shares into the Q3 data. The stock has upside to $7 on positive data and downside to $2.25 on a negative readout, Andrews contends. He keeps a Buy rating on Amarin with a $7 price target.
05/25/18
CANT
05/25/18
NO CHANGE
Target $10
CANT
Overweight
Amarin settlement terms with Teva favorable, says Cantor Fitzgerald
Cantor Fitzgerald analyst Louise Chen believes the terms of the settlement agreement with Teva (TEVA) resolving Vascepa patent litigation are favorable to Amarin (AMRN). Under the settlement, Teva will not begin selling generic Vascepa in the U.S. until August 9, 2029, which is just six months off the expiry date of Vascepa's patents, Chen tells investors in a research note. She keeps an Overweight rating on Amarin with a $10 price target.

TODAY'S FREE FLY STORIES

PINC

Premier

$38.38

0.24 (0.63%)

09:15
08/20/18
08/20
09:15
08/20/18
09:15
Hot Stocks
Premier to provide operational transformation consulting to UofL Hospital, ULP »

Premier has expanded its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 05

    Sep

  • 14

    Sep

OPTT

Ocean Power

$0.76

0.0501 (7.06%)

, E

Eni SpA

$36.28

0.12 (0.33%)

09:14
08/20/18
08/20
09:14
08/20/18
09:14
Hot Stocks
Ocean Power ships PB3 PowerBuoy to Eni SpA »

Ocean Power (OPTT)…

OPTT

Ocean Power

$0.76

0.0501 (7.06%)

E

Eni SpA

$36.28

0.12 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SODA

SodaStream

$129.89

1.12 (0.87%)

, PEP

PepsiCo

$114.98

0.7 (0.61%)

09:14
08/20/18
08/20
09:14
08/20/18
09:14
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: SodaStream…

SODA

SodaStream

$129.89

1.12 (0.87%)

PEP

PepsiCo

$114.98

0.7 (0.61%)

TSLA

Tesla

$305.33

-30.13 (-8.98%)

MIXT

MiX Telematics

$15.09

-0.17 (-1.11%)

NKE

Nike

$79.73

-0.32 (-0.40%)

BBOX

Black Box

$1.64

0.09 (5.81%)

LCI

Lannett

$13.50

-0.25 (-1.82%)

INFY

Infosys

$21.09

0.095 (0.45%)

STZ

Constellation Brands, also tag STZ.B

$203.90

1.47 (0.73%)

NWS

News Corp

$14.40

0.1 (0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 28

    Aug

  • 12

    Sep

  • 02

    Oct

  • 28

    Oct

  • 29

    Oct

AKAO

Achaogen

$5.91

0.21 (3.68%)

09:13
08/20/18
08/20
09:13
08/20/18
09:13
Recommendations
Achaogen analyst commentary  »

Achaogen price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Aug

  • 31

    Aug

TSLA

Tesla

$305.33

-30.13 (-8.98%)

09:13
08/20/18
08/20
09:13
08/20/18
09:13
Recommendations
Tesla analyst commentary  »

Tesla price target cut to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

RADA

RADA Electronic

$2.52

-0.02 (-0.79%)

09:11
08/20/18
08/20
09:11
08/20/18
09:11
Hot Stocks
RADA Electronic's MHR to be delivered to the British Army »

RADA Electronic announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:10
08/20/18
08/20
09:10
08/20/18
09:10
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

LTBR

Lightbridge

$0.87

0.004 (0.46%)

09:08
08/20/18
08/20
09:08
08/20/18
09:08
Hot Stocks
Lightbridge CFO Linda Zwobota to retire, Larry Goldman to succeed »

Lightbridge announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$217.65

4.16 (1.95%)

09:05
08/20/18
08/20
09:05
08/20/18
09:05
Downgrade
Apple rating change  »

Apple downgraded to Sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:05
08/20/18
08/20
09:05
08/20/18
09:05
General news
Treasury Action: yields have extended early declines »

Treasury Action: yields…

JCP

J.C. Penney

$1.79

0.025 (1.42%)

09:04
08/20/18
08/20
09:04
08/20/18
09:04
Hot Stocks
J.C. Penney unveils new, exclusive big & tall brand with Shaquille O'Neal »

Building on the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICHR

Ichor Holdings

$21.32

-0.57 (-2.60%)

09:04
08/20/18
08/20
09:04
08/20/18
09:04
Hot Stocks
Ichor Holdings announces $50M increase to share repurchase program »

Ichor Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

IVAC

Intevac

$5.03

0.225 (4.69%)

09:03
08/20/18
08/20
09:03
08/20/18
09:03
Hot Stocks
Intevac announces $10M expansion of existing $30M share repurchase program »

Intevac announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BXP

Boston Properties

$132.14

0.5 (0.38%)

09:02
08/20/18
08/20
09:02
08/20/18
09:02
Recommendations
Boston Properties analyst commentary  »

Boston Properties price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RICK

RCI Hospitality

$32.61

0.36 (1.12%)

09:02
08/20/18
08/20
09:02
08/20/18
09:02
Hot Stocks
RCI Hospitality to acquire Blush Gentlemen's Club & Sports Bar for $15M »

RCI Hospitality announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GWRE

Guidewire

$95.23

-1.47 (-1.52%)

08:58
08/20/18
08/20
08:58
08/20/18
08:58
Hot Stocks
Guidewire contributes to report on cyber insurance market »

Guidewire Software helped…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 12

    Sep

AAPL

Apple

$217.65

4.16 (1.95%)

, TSLA

Tesla

$305.33

-30.13 (-8.98%)

08:55
08/20/18
08/20
08:55
08/20/18
08:55
Options
Notable open interest changes for August 20th »

Friday's total…

AAPL

Apple

$217.65

4.16 (1.95%)

TSLA

Tesla

$305.33

-30.13 (-8.98%)

BABA

Alibaba

$172.76

0.78 (0.45%)

FB

Facebook

$173.78

-0.98 (-0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 23

    Aug

  • 06

    Sep

  • 10

    Sep

  • 18

    Sep

  • 29

    Oct

PAY

Verifone

$23.04

0.01 (0.04%)

08:54
08/20/18
08/20
08:54
08/20/18
08:54
Hot Stocks
Breaking Hot Stocks news story on Verifone »

Verifone trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LQDA

Liquidia Technologies

$14.30

-0.12 (-0.83%)

08:52
08/20/18
08/20
08:52
08/20/18
08:52
Initiation
Liquidia Technologies initiated  »

Liquidia Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$9.56

0.04 (0.42%)

08:51
08/20/18
08/20
08:51
08/20/18
08:51
Recommendations
Ford analyst commentary  »

Ford risks high, but so…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Aug

TNDM

TNDM

, DXCM

DexCom

$130.93

2.61 (2.03%)

08:51
08/20/18
08/20
08:51
08/20/18
08:51
Recommendations
TNDM, DexCom analyst commentary  »

Tandem Diabetes price…

TNDM

TNDM

DXCM

DexCom

$130.93

2.61 (2.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 27

    Aug

  • 12

    Sep

  • 13

    Sep

  • 20

    Sep

  • 21

    Sep

08:50
08/20/18
08/20
08:50
08/20/18
08:50
General news
Fedspeak from Atlanta Fed dove Bostic »

Fedspeak from Atlanta Fed…

VERI

Veritone

$11.41

0.11 (0.97%)

08:49
08/20/18
08/20
08:49
08/20/18
08:49
Conference/Events
Veritone to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

VMC

Vulcan Materials

$110.31

0.46 (0.42%)

08:47
08/20/18
08/20
08:47
08/20/18
08:47
Recommendations
Vulcan Materials analyst commentary  »

Vulcan Materials price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

  • 06

    Nov

MLCO

Melco Resorts & Entertainment

$22.08

0.56 (2.60%)

08:47
08/20/18
08/20
08:47
08/20/18
08:47
Hot Stocks
Melco Resorts & Entertainment subsidiary provides update on IPO »

Studio City International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.